Article
Understanding the Uptake and Challenges of Genetic Testing Guidelines for Prostate Cancer Patients.
Cancer treatment and research communications - 1 Jan 2022
Suri Yash, Yasmeh Jonathan Parham, Basu Arnab
Abstract excerpt
BACKGROUND: Multiple studies have confirmed a high prevalence of prognostic germline mutations in prostate cancer. In recognition, the NCCN guidelines and recommendations for genetic counselling (GC) in prostate cancer patients were expanded. METHODS: Data on prostate cancer patients at a single tertiary cancer center from January 2019 - June 2019 were queried. The cohort of patients from the queried list were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
